Enhanced Regioselectivity and Catalytic Activity on C7Hydroxylation of Lithocholic Acid to Produce Ursodeoxycholic Acid by Monooxygenase CYP107D1 Based on Semi‐Rational Design
Biotechnology Journal · 2025
DOI: 10.1002/biot.70070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2025. Verfasst von Ci Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University …. Hauptthemen laut MEDLINE: Lithocholic Acid, Ursodeoxycholic Acid, Cytochrome P-450 Enzyme System, Bacterial Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Guangdong Provincial Key Research and Development Program, Science and Technology Innovation Project of Guangdong Provincial Medical Products Administration.
Abstract (Originalsprache)
Ursodeoxycholic acid (UDCA), a natural bile acid, is widely utilized in treating hepatobiliary disorders due to its ability to reduce bile concentration and protect liver function. While the CYP107D1 (OleP) triple‐mutant F84Q/S240A/V291G is the first identified bacterial monooxygenase capable of directly converting lithocholic acid (LCA) to UDCA via C7β‐hydroxylation, its industrial application has been hindered by low catalytic efficiency. The study implemented a semi‐rational design strategy combined with a cell‐free enzyme catalysis method, utilizing the OleP triple mutant as a template, to screen for mutants with enhanced 7β‐hydroxylation activity. The superior quadruple‐mutant G294A/N236H/F321W/V297A was engineered through iterative combinatorial mutagenesis, which catalyzed the production of about 0.68 mM UDCA from 1 mM substrate LCA. This variant exhibited a 50% increase in catalytic activity and a 40% improvement in regioselectivity compared to the template OleP triple‐mutant. Molecular docking and kinetic simulations further demonstrated that the quadruple mutant stabilized the enzyme‐substrate complex through optimized binding interactions, thereby enhancing catalytic proficiency. Our findings elucidate critical structural determinants governing C7‐hydroxylation of LCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, P. R. China.
- Zhongshan PASSION Biotechnology Co., Ltd., Zhongshan, P. R. China.
Förderung
- Guangdong Provincial Key Research and Development Program
- Science and Technology Innovation Project of Guangdong Provincial Medical Products Administration
Zitieren
APA
Song, C., Zheng, X., Zhou, Z., Yu, Y., Zhang, L., & Li, S. (2025). Enhanced Regioselectivity and Catalytic Activity on C7Hydroxylation of Lithocholic Acid to Produce Ursodeoxycholic Acid by Monooxygenase CYP107D1 Based on Semi‐Rational Design. Biotechnology Journal. https://doi.org/10.1002/biot.70070
Vancouver
Song C, Zheng X, Zhou Z, Yu Y, Zhang L, Li S. Enhanced Regioselectivity and Catalytic Activity on C7Hydroxylation of Lithocholic Acid to Produce Ursodeoxycholic Acid by Monooxygenase CYP107D1 Based on Semi‐Rational Design. Biotechnology Journal. 2025. doi:10.1002/biot.70070
BibTeX
@article{Song2025,
author = {Song, Ci and Zheng, Xiaomin and Zhou, Zhenru and Yu, Yundong and Zhang, Lei and Li, Shan},
title = {Enhanced Regioselectivity and Catalytic Activity on C7Hydroxylation of Lithocholic Acid to Produce Ursodeoxycholic Acid by Monooxygenase CYP107D1 Based on Semi‐Rational Design},
journal = {Biotechnology Journal},
year = {2025},
doi = {10.1002/biot.70070}
}
EUVIMED